학술논문
Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer in the APHINITY trial.
Document Type
Article
Author
Source
Breast Cancer Research Review; 2021, Issue 34, p5-5, 1/3p
Subject
Language
ISSN
11794976
Abstract
Copyright of Breast Cancer Research Review is the property of Research Review Ltd. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)